Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc by (c) Velasco, Roser; Bruna, Jordi, 2015
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126095

Taxane-induced Peripheral Neurotoxicity

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Taxane-derived agents are chemotherapy drugs widely employed in cancer treatment. Among them, paclitaxel and docetaxel are most commonly administered, but newer formulations are being investigated. Taxane antineoplastic activity is mainly based on the ability of the drugs to promote microtubule assembly, leading to mitotic arrest and apoptosis in cancer cells. Peripheral neurotoxicity is the major non-hematological adverse effect of taxane, often manifested as painful neuropathy experienced during treatment, and it is sometimes irreversible. Unfortunately, taxane-induced neurotoxicity is an uncertainty prior to the initiation of treatment. The present review aims to dissect current knowledge on real incidence, underlying pathophysiology, clinical features and predisposing factors related with the development of taxane-induced neuropathy.

Subject (English)

Citation

Citation

VELASCO, Roser and BRUNA, Jordi. Taxane-induced Peripheral Neurotoxicity. Toxics. 2015. Vol. 3, num. 2, pags. 152-169. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/126095

Export metadata

JSON - METS

Share record